Endsulin Overview

Status Private
Latest Deal Type Angel
Investors 1

Endsulin General Information


Provider of medical research services intended to cure Type I Diabetes with gene therapy. The company's services are primarily engaged in discovering glucose-inducible insulin transgene (glucose inducible responsive element, or GIRE) and a method for obtaining glucose-regulated expression of active insulin in mammalian cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Primary Office
  • 1206 Sherman Avenue
  • Madison, WI 53703
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endsulin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Generating Revenue

Endsulin Executive Team (1)

Name Title Board Seat Contact Info
Hans Sollinger MD Founder

Endsulin Investors (1)

To view Endsulin‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jeffrey Rusinow Angel (individual) Minority 000 0000 000000 0

Ready to get started?

Request a free trial